Strong effect of mogamulizumab on splenic residual disease of adult T cell leukemia/lymphoma.
Department of Hematology and Oncology, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan, giya_pen_1213.0@triton.ocn.ne.jp.
Daisuke
D
Ohgiya
Shinichiro
S
Machida
Akihumi
A
Ichiki
Jun
J
Amaki
Yasuyuki
Y
Aoyama
Hidetsugu
H
Kawai
Mitsuki
M
Miyamoto
Hiromichi
H
Murayama
Makoto
M
Onizuka
Kiyoshi
K
Ando
D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D008875:Middle Aged; D018365:Neoplasm, Residual; D011877:Radionuclide Imaging; D013154:Spleen / Q000000981:diagnostic imaging*; D016896:Treatment Outcome
D061067:Antibodies, Monoclonal, Humanized; C549035:mogamulizumab